Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1987 Feb;71(2):118–125. doi: 10.1136/bjo.71.2.118

The enigma of herpes stromal disease.

J McGill
PMCID: PMC1041102  PMID: 3548807

Abstract

Herpes stromal disease is due to direct damage as a result of viral replication, virally induced immune mechanisms, or a combination of the two. Viral replication may have a major initiating role in the production of herpes simplex and herpes zoster induced stromal disease, and steroids may initially be harmful in their treatment. On topical antiviral drugs alone, in patients who never previously had had topical steroids, 14 of 15 cases of herpes simplex induced disciform keratitis responded favourably in an average of 44 days of treatment. This compared with one out of 14 responding if steroids had previously been used, 13 of 14 requiring topical steroids and an average 112 days' treatment. In herpes zoster stromal disease cases 78% had epithelial involvement, 54 of 57 responded to topical antivirals alone without the use of steroids, 2% recurred, and treatment averaged a total of 62 days. If steroids were used alone or in combination with antivirals, there was a 50% recurrence rate and 200 day total treatment duration.

Full text

PDF
118

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour H. H., Jr Resistance of herpes simplex to acyclovir. Ann Intern Med. 1983 Mar;98(3):404–406. doi: 10.7326/0003-4819-98-3-404. [DOI] [PubMed] [Google Scholar]
  2. Baringer J. R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. doi: 10.1056/NEJM197303292881303. [DOI] [PubMed] [Google Scholar]
  3. Bean B., Braun C., Balfour H. H., Jr Acyclovir therapy for acute herpes zoster. Lancet. 1982 Jul 17;2(8290):118–121. doi: 10.1016/s0140-6736(82)91090-x. [DOI] [PubMed] [Google Scholar]
  4. Burns W. H., Saral R., Santos G. W., Laskin O. L., Lietman P. S., McLaren C., Barry D. W. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet. 1982 Feb 20;1(8269):421–423. doi: 10.1016/s0140-6736(82)91620-8. [DOI] [PubMed] [Google Scholar]
  5. Centifanto-Fitzgerald Y. M., Fenger T., Kaufman H. E. Virus proteins in herpetic keratitis. Exp Eye Res. 1982 Nov;35(5):425–441. doi: 10.1016/0014-4835(82)90041-0. [DOI] [PubMed] [Google Scholar]
  6. Cobo L. M., Foulks G. N., Liesegang T., Lass J., Sutphin J., Wilhelmus K., Jones D. B., Chapman S., Segreti A. Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report. Ophthalmology. 1985 Nov;92(11):1574–1583. doi: 10.1016/s0161-6420(85)33842-3. [DOI] [PubMed] [Google Scholar]
  7. Collin H. B., Abelson M. B. Herpes simplex virus in human cornea, retrocorneal fibrous membrane, and vitreous. Arch Ophthalmol. 1976 Oct;94(10):1726–1729. doi: 10.1001/archopht.1976.03910040500007. [DOI] [PubMed] [Google Scholar]
  8. Davis C. M., VanDersarl J. V., Coltman C. A., Jr Failure of cytarabine in varicella-zoster infections. JAMA. 1973 Apr 2;224(1):122–123. [PubMed] [Google Scholar]
  9. Dawson C., Togni B., Moore T. E., Jr Structural changes in chronic herpetic keratitis. Studied by light and electron microscopy. Arch Ophthalmol. 1968 Jun;79(6):740–747. doi: 10.1001/archopht.1968.03850040742016. [DOI] [PubMed] [Google Scholar]
  10. ELLIOTT F. A. TREATMENT OF HERPES ZOSTER WITH HIGH DOSES OF PREDNISONE. Lancet. 1964 Sep 19;2(7360):610–611. doi: 10.1016/s0140-6736(64)90507-0. [DOI] [PubMed] [Google Scholar]
  11. Hedges T. R., 3rd, Albert D. M. The progression of the ocular abnormalities of herpes zoster. Histopathologic observations of nine cases. Ophthalmology. 1982 Feb;89(2):165–177. doi: 10.1016/s0161-6420(82)34842-3. [DOI] [PubMed] [Google Scholar]
  12. Jones B. R., Falcon M. G., Williams H. P., Coster D. J. Objectives in therapy of herpetic eye disease. Trans Ophthalmol Soc U K. 1977 Jul;97(2):305–313. [PubMed] [Google Scholar]
  13. Juel-Jensen B. E., MacCallum F. O., Mackenzie A. M., Pike M. C. Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J. 1970 Dec 26;4(5738):776–780. doi: 10.1136/bmj.4.5738.776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kaufman H. E., Varnell E. D., Centifanto Y. M., Kissling G. E. Effect of the herpes simplex virus genome on the response of infection to corticosteroids. Am J Ophthalmol. 1985 Jul 15;100(1):114–118. doi: 10.1016/s0002-9394(14)74992-x. [DOI] [PubMed] [Google Scholar]
  15. Liesegang T. J. Corneal complications from herpes zoster ophthalmicus. Ophthalmology. 1985 Mar;92(3):316–324. doi: 10.1016/s0161-6420(85)34034-4. [DOI] [PubMed] [Google Scholar]
  16. Marsh R. J., Fraunfelder F. T., McGill J. I. Herpetic corneal epithelial disease. Arch Ophthalmol. 1976 Nov;94(11):1899–1902. doi: 10.1001/archopht.1976.03910040609004. [DOI] [PubMed] [Google Scholar]
  17. Marsh R. J. Herpes zoster keratitis. Trans Ophthalmol Soc U K. 1973;93(0):181–192. [PubMed] [Google Scholar]
  18. Maudgal P. C., De Clercq E., Descamps J., Missotten L., Wijnhoven J. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine. Arch Ophthalmol. 1982 Apr;100(4):653–656. doi: 10.1001/archopht.1982.01030030655027. [DOI] [PubMed] [Google Scholar]
  19. Maudgal P. C., Missotten L., De Clercq E., Descamps J. Varicella-zoster virus in the human corneal endothelium: a case report. Bull Soc Belge Ophtalmol. 1980;190:71–86. [PubMed] [Google Scholar]
  20. McGill J., Chapman C. A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis. Br J Ophthalmol. 1983 Nov;67(11):746–750. doi: 10.1136/bjo.67.11.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McGill J., MacDonald D. R., Fall C., McKendrick G. D., Copplestone A. Intravenous acyclovir in acute herpes zoster infection. J Infect. 1983 Mar;6(2):157–161. doi: 10.1016/s0163-4453(83)92787-1. [DOI] [PubMed] [Google Scholar]
  22. McGill J. Topical acyclovir in herpes zoster ocular involvement. Br J Ophthalmol. 1981 Aug;65(8):542–545. doi: 10.1136/bjo.65.8.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McGill J., Tormey P., Walker C. B. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol. 1981 Sep;65(9):610–613. doi: 10.1136/bjo.65.9.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McGill J., Williams H., McKinnon J., Holt-Wilson A. D., Jones B. R. Reassessment of idoxuridine therapy of herpetic keratitis. Trans Ophthalmol Soc U K. 1974 Jul;94(2):542–552. [PubMed] [Google Scholar]
  25. McNeill J. I., Kaufman H. E. Local antivirals in a herpes simplex stromal keratitis model. Arch Ophthalmol. 1979 Apr;97(4):727–729. doi: 10.1001/archopht.1979.01020010379022. [DOI] [PubMed] [Google Scholar]
  26. Metcalf J. F., Kaufman H. E. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am J Ophthalmol. 1976 Dec;82(6):827–834. doi: 10.1016/0002-9394(76)90057-x. [DOI] [PubMed] [Google Scholar]
  27. Meyers-Elliott R. H., Chitjian P. A. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody. Invest Ophthalmol Vis Sci. 1980 Aug;19(8):920–929. [PubMed] [Google Scholar]
  28. Meyers-Elliott R. H., Elliott J. H., Chitjian P. A., Ho P. C. Humoral and cell-mediated immune responses to epidermal growth factor in the rabbit. Invest Ophthalmol Vis Sci. 1981 Jan;20(1):86–99. [PubMed] [Google Scholar]
  29. Meyers-Elliott R. H., Pettit T. H., Maxwell W. A. Viral antigens in the immune ring of Herpes simplex stromal keratitis. Arch Ophthalmol. 1980 May;98(5):897–904. doi: 10.1001/archopht.1980.01020030891018. [DOI] [PubMed] [Google Scholar]
  30. Opremcak E. M., Whisler R. L., Dangel M. E. Natural killer cells against human corneal endothelium. Am J Ophthalmol. 1985 May 15;99(5):524–529. doi: 10.1016/s0002-9394(14)77950-4. [DOI] [PubMed] [Google Scholar]
  31. Patterson A., Jones B. R. The management of ocular herpes. Trans Ophthalmol Soc U K. 1967;87:59–84. [PubMed] [Google Scholar]
  32. Pavan-Langston D. Varicella-zoster ophthalmicus. Int Ophthalmol Clin. 1975 Winter;15(4):171–185. doi: 10.1097/00004397-197501540-00015. [DOI] [PubMed] [Google Scholar]
  33. Peterslund N. A., Seyer-Hansen K., Ipsen J., Esmann V., Schonheyder H., Juhl H. Acyclovir in herpes zoster. Lancet. 1981 Oct 17;2(8251):827–830. doi: 10.1016/s0140-6736(81)91102-8. [DOI] [PubMed] [Google Scholar]
  34. Sanitato J. J., Asbell P. A., Varnell E. D., Kissling G. E., Kaufman H. E. Acyclovir in the treatment of herpetic stromal disease. Am J Ophthalmol. 1984 Nov;98(5):537–547. doi: 10.1016/0002-9394(84)90237-x. [DOI] [PubMed] [Google Scholar]
  35. Schwartz J. N., Cashwell F., Hawkins H. K., Klintworth G. K. Necrotizing retinopathy with herpes zoster ophthalmicus: a light and electron microscopical study. Arch Pathol Lab Med. 1976 Jul;100(7):386–391. [PubMed] [Google Scholar]
  36. Swyers J. S., Lausch R. N., Kaufman H. E. Corneal hypersensitivity to herpes simplex. Br J Ophthalmol. 1967 Dec;51(12):843–846. doi: 10.1136/bjo.51.12.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. THYGESON P., KIMURA S. J. Deep forms of herpetic keratitis. Am J Ophthalmol. 1957 Apr;43(4 Pt 2):109–113. doi: 10.1016/0002-9394(57)91491-5. [DOI] [PubMed] [Google Scholar]
  38. Treseler P. A., Foulks G. N., Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol. 1984 Dec 15;98(6):763–772. doi: 10.1016/0002-9394(84)90696-2. [DOI] [PubMed] [Google Scholar]
  39. Tullo A. B., Shimeld C., Blyth W. A., Hill T. J., Easty D. L. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J Gen Virol. 1982 Nov;63(Pt 1):95–101. doi: 10.1099/0022-1317-63-1-95. [DOI] [PubMed] [Google Scholar]
  40. Wildenhoff K. E., Ipsen J., Esmann V., Ingemann-Jensen J., Poulsen J. H. Treatment of herpes zoster with idoxuridine ointment, including a multivariate analysis of symptoms and signs. Scand J Infect Dis. 1979;11(1):1–9. doi: 10.3109/inf.1979.11.issue-1.01. [DOI] [PubMed] [Google Scholar]
  41. Wilhelmus K. R., Coster D. J., Donovan H. C., Falcon M. G., Jones B. R. Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol. 1981 Sep;99(9):1578–1582. doi: 10.1001/archopht.1981.03930020452009. [DOI] [PubMed] [Google Scholar]
  42. Wilhelmus K. R., Falcon M. G., Jones B. R. Herpetic iridocyclitis. Int Ophthalmol. 1982 Feb;4(3):143–150. doi: 10.1007/BF00161904. [DOI] [PubMed] [Google Scholar]
  43. Witmer R., Iwamoto T. Electron microscope observation of herpes-like particles in the iris. Arch Ophthalmol. 1968 Mar;79(3):331–337. doi: 10.1001/archopht.1968.03850040333019. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES